GCS
WST icon

Gordian Capital (Singapore)’s West Pharmaceutical WST Stock Holding History

Gordian Capital (Singapore)’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,250
Closed -$344K – 177
2025
Q4 		$344K Buy
+1,250
New +$342K 0.48% 47
2025
Q1 		– Sell
-5,700
Closed -$1.87M – 189
2024
Q4 		$1.87M Buy
5,700
+3,555
+166% +$1.12M 0.97% 24
2024
Q3 		$644K Buy
2,145
+841
+64% +$258K 0.24% 52
2024
Q2 		$430K Buy
+1,304
New +$461K 0.24% 48

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Generation Investment Management
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Gordian Capital (Singapore)'s WST Position: Q1 2026 in Review

Gordian Capital (Singapore) sold out of West Pharmaceutical (WST) in Q1 2026, closing a stake of 1,250 shares — an estimated $344K sold.

Gordian Capital (Singapore) first reported a position in WST in Q2 2024 and held it in 4 quarters. The position peaked at $1.87M in Q4 2024. 755 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Gordian Capital (Singapore) reported no remaining West Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • Gordian Capital (Singapore) sold 1,250 West Pharmaceutical shares in Q1 2026, an estimated $344K.
  • Gordian Capital (Singapore) first reported a position in West Pharmaceutical in Q2 2024 and held it in 4 quarters.
  • Gordian Capital (Singapore)'s West Pharmaceutical position peaked at $1.87M in Q4 2024.
  • 755 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Gordian Capital (Singapore)'s 13F filing for Q1 2026, filed 13 May 2026.